NCT00241488
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Beijing, China
- Ching Qing, China
- Guangzhou, China
- Harbin, China
Clinical trial condition
Dyslipidemias
Explore clinical trials studying Dyslipidemias. Study availability and eligibility vary by location and protocol.
1,824 public trials
142 recruiting studies
Dyslipidemias trial results
NCT00115232
- Conditions
- Cardiovascular Disease, Cardiovascular Diseases, Dyslipidemias, +13 more
- Locations
-
- Children's Hospital Boston Boston, Massachusetts, United States
NCT00222833
- Conditions
- Body Weight, Cardiovascular Diseases, Dyslipidemias, +15 more
- Locations
-
- Western Psychiatric Institute and Clinic of UPMC Pittsburgh, Pennsylvania, United States
NCT00574782
- Conditions
- CVA, Cardiovascular Diseases, Coronary Disease, +16 more
- Locations
-
Not specified
NCT00335699
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Research Site Daegu, South Korea
- Research Site Iksan, South Korea
- Research Site Jeonju, South Korea
- Research Site Jinju, South Korea
NCT00134173
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +12 more
- Locations
-
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Mobile, Alabama, United States
- Pfizer Investigational Site Little Rock, Arkansas, United States
- Pfizer Investigational Site Fresno, California, United States
NCT00566267
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
Not specified
NCT00542867
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
Not specified
NCT00134498
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
- Locations
-
- Pfizer Investigational Site Anaheim, California, United States
- Pfizer Investigational Site Huntington Beach, California, United States
- Pfizer Investigational Site Los Angeles, California, United States
- Pfizer Investigational Site Orange, California, United States
NCT00454831
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- JSS Medical Research Inc. Westmount, Quebec, Canada